Comparison of Effectiveness Between Vedolizumab and Ustekinumab in Crohn’s Disease: A Real-World Multicenter Study From Gün-Türk IBD Group, Turkey
Background and Aims: Optimal sequencing of therapy in Crohn’s disease (CD) after anti-tumor necrosis factor (TNF) failure remains uncertain. We compared the real-world effectiveness and safety of vedolizumab (VDZ) and ustekinumab (UST) in this setting. Materials and Methods: This retrospective multicenter cohort included 482 patients with moderate-to-severe CD from 14 tertiary centers in Turkey who received VDZ (n = 247) or UST (n = 235) after ≥1 anti-TNF. Clinical remission (CR; Harvey–Bradshaw Index <5) and steroid-free CR (SFCR) at weeks 14 and 52 were primary outcomes. Long-term response, treatment persistence, and safety were also assessed using inverse probability of treatment weighting. Results: At week 14, UST showed higher CR [adjusted odds ratio (aOR) = 1.49, 95% CI: 1.15-1.94] and SFCR (aOR = 1.42, 95% CI: 1.10-1.83) than VDZ. Superiority persisted in patients with prior biological exposure, though outcomes were similar among those with ≥2 biologics. At weeks 52 and 104, CR and SFCR rates were comparable between groups. Treatment persistence was significantly greater with UST (78.5% vs. 53.1% after inverse probability of treatment weighting; aOR = 3.22, 95% CI: 2.43-4.27), and secondary loss of response was lower (14.5% vs. 38.5%, P < 0.001). Adverse events were infrequent and similar across groups, with few serious events. Conclusions: In anti-TNF–experienced CD, UST provided superior early remission and higher treatment persistence compared with VDZ, while long-term efficacy and safety were similar. UST may be favored where rapid disease control and treatment durability are required, though both agents remain important therapeutic options.
Authors
- Göksel Bengı (ORCID: https://orcid.org/0000-0002-7859-4094)
- Banu Kara (ORCID: https://orcid.org/0000-0003-4278-6593)
- Emre Odabaş (ORCID: https://orcid.org/0000-0002-9982-0257)
- Ayhan Hilmi Çekın (ORCID: https://orcid.org/0000-0001-7464-8297)
- Nevin Oruç (ORCID: https://orcid.org/0000-0002-3057-6452)
- Burak Özşeker (ORCID: https://orcid.org/0000-0001-5429-513X)
- Elmas Kasap (ORCID: https://orcid.org/0000-0002-4335-1156)
- Elif Tuğba Tuncel (ORCID: https://orcid.org/0000-0002-0908-1949)
- Fehmi Ateş (ORCID: https://orcid.org/0000-0003-2527-414X)
- Hale Akpınar (ORCID: https://orcid.org/0000-0002-8734-2518)
- Filiz Araz (ORCID: https://orcid.org/0000-0003-0780-5680)
- Ümit Karaoğullarından (ORCID: https://orcid.org/0000-0003-4309-7845)
- Nalan Gülşen Ünal (ORCID: https://orcid.org/0000-0001-8870-2450)
- Ferda Akbay Harmandar (ORCID: https://orcid.org/0000-0002-7897-6658)
- Süleyman Dolu (ORCID: https://orcid.org/0000-0002-7496-9493)
- Enver Uçbılek (ORCID: https://orcid.org/0000-0002-2935-5580)
- Nimet Yılmaz (ORCID: https://orcid.org/0000-0002-3092-6037)
- Gülşah Şeydaoğlu (ORCID: https://orcid.org/0000-0002-0899-894X)
- Kadri Atay (ORCID: https://orcid.org/0000-0002-7570-3638)
- Sezgin Barutçu (ORCID: https://orcid.org/0000-0003-0823-3215)
- Engin Altıntaş (ORCID: https://orcid.org/0000-0003-0796-1456)
- Taner Kara (ORCID: https://orcid.org/0000-0002-0494-5736)
- Galip Egemen Atar (ORCID: https://orcid.org/0000-0002-0816-8719)
- Kadir Gişi (ORCID: https://orcid.org/0000-0003-4082-4832)
- Halil Çapar (ORCID: https://orcid.org/0009-0003-3671-4355)
- Zekiye Nur Harput (ORCID: https://orcid.org/0000-0002-7969-7968)
- Birol Özer (ORCID: https://orcid.org/0000-0001-8154-5229)
- B. Tasdogan (ORCID: https://orcid.org/0000-0003-2052-2124)
- Mesut Kuş (ORCID: https://orcid.org/0009-0009-0709-7275)
- B M Aykut (ORCID: https://orcid.org/0009-0006-5080-9440)
- Orhan Sezgin (ORCID: https://orcid.org/0000-0002-6704-4716)
- Mehmet Ali Şahan (ORCID: https://orcid.org/0009-0005-4721-1686)
- Etibar Mamadov
- Deha Çetin
- Gözde Derviş Hakim
- Sevinç Püren Yücel
Institutions
- Izmir University (TR)
- Manisa Celal Bayar University (TR)
- Başkent University (TR)
- Dokuz Eylül University (TR)
- Mardin Artuklu University (TR)
- Ege University (TR)
- Antalya Eğitim ve Araştırma Hastanesi (TR)
- Başkent University Hospital (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Sanko University (TR)
- Mersin Üniversitesi (TR)
- Cukurova University (TR)
- Gaziantep University (TR)
- Muğla University (TR)
Publication Details
- Journal
- Journal of Clinical Gastroenterology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1097/mcg.0000000000002474
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00